Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil

Braz J Infect Dis. 2015 Sep-Oct;19(5):486-91. doi: 10.1016/j.bjid.2015.06.007. Epub 2015 Aug 5.

Abstract

Background: While 20-40% of patients with hepatitis C virus (HCV) monoinfection will spontaneously clear the virus, less is known regarding clearance with coinfections. HCV, human immunodeficiency virus (HIV), and human T-cell lymphotrophic virus 1 and 2 (HTLV-1/2) coinfection occurs due to shared routes of transmission and is prevalent in Brazil.

Objectives: To compare the proportion of patients who have spontaneously cleared HCV in patients with HCV monoinfection to patients coinfected by HCV/HIV, or HCV/HIV/HTLV-1.

Methods: Using medical records from two clinics in Salvador, Brazil, including demographic data and serological markers of HCV, HIV and HTLV-I/II, cross-sectional data was obtained from 197 patients. Patients who were anti-HCV positive and HCV RNA negative, and who did not receive HCV treatment were defined as having cleared infection.

Results: Nineteen patients (9.5%) showed evidence of spontaneous HCV clearance; with clearance in 9 of 108 (8.3%) patients in the HCV monoinfected group, 5 of 68 (7.4%) patients with HCV/HIV, and 5 of 21 (23.8%) patients with HCV/HIV/HTLV. Demographic data were not associated with HCV clearance status. Patients coinfected with both HIV and HTLV-1 had increased odds (5.50; 95% CI 1.00, 30.17) of spontaneous clearance of HCV compared with patients who were HIV negative or of unknown HIV status.

Conclusion: Our study found that patients coinfected with HIV and HTLV-1 were more likely to spontaneously clear hepatitis C virus than patients with HIV/HCV or HCV alone. The effects of HTLV coinfection on the immune response of such patients may be associated with these findings.

Keywords: Brazil; HIV; HTLV-1; Hepatitis C; Spontaneous HCV clearance.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Brazil
  • Coinfection / virology*
  • Cross-Sectional Studies
  • Female
  • HIV Infections / complications*
  • HTLV-I Infections / complications*
  • Hepatitis C / complications*
  • Hepatitis C / virology
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • RNA, Viral
  • Virus Shedding*

Substances

  • RNA, Viral